Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders diagnosed in children. The CDC estimates that over 6 million children have been diagnosed with ADHD, which translates into about 9.4% of children aged 4-17.
Have you been considering having your child tested for Attention Deficit Hyperactivity Disorder (ADHD)? Perhaps you’ve noticed behaviors that your child has that are different from his or her peers. Or maybe your child’s teacher has reported his behaviors are preventing him from doing as well as he could in his schoolwork.
Children with Attention Deficit Hyperactivity Disorder (ADHD) often have a constellation of symptoms including inattention, impulsivity, difficulty focusing, and hyperactivity. For many children, there is another symptom that is often overlooked: managing emotions. Despite its prevalence among children and teens with ADHD, it is not one of the diagnostic criteria of ADHD.
There is a new medication to treat Attention Deficit Hyperactivity Disorder (ADHD) available through your child and adolescent psychiatrist. Jornay PM is a stimulant used to treat ADHD symptoms in children six years and older. Jornay PM is a methylphenidate-based medication, but it has a special feature. Taken at night, Jornay PM has been shown to control ADHD symptoms from the time the child wakes up in the morning and keeps working right through the day.